University Hospital of Cologne

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University Hospital of Cologne sits in the upper half of US sponsors by registered trial count (#7,388 of 15,742 sponsors by registered trial count).

1 total trials 1 currently recruiting upper half by trial count

University Hospital of Cologne: 1 sponsored US clinical trial, 1 recruiting.

University Hospital of Cologne sponsors 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Mitral Insufficiency, with 1 trials.

Mid-pack sponsor footprint

University Hospital of Cologne is in the upper half of sponsors by trial count (#7,388 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.

What is open in the University Hospital of Cologne pipeline

1 recruiting of 1 indexed (100% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Mitral Insufficiency (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University Hospital of Cologne: open-pipeline peers nationwide

Peers matched on 1 registered trials and 100% open enrollment, not the therapeutic-area sidebar.

University Hospital of Cologne sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 012345 0%50%100%150% Total trials Recruiting share University Hospital of Cologne1200 Pharma1ST Biotherapeutics3 Waves Wellness3EO HealthAAVantgarde Bio SrlAcorn BiolabsAcrivon TherapeuticsADARx Pharmaceuticals
University Hospital of Cologne sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University Hospital of Cologne sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1 trials (± recruiting share)

Sponsors near 100% open enrollment (± trial volume)

What to do with this University Hospital of Cologne page

1 registered trials is a research-attention snapshot, not an endorsement of University Hospital of Cologne or any single study.

  • 1 of University Hospital of Cologne's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Mitral Insufficiency is the condition University Hospital of Cologne studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Mitral Insufficiency trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University Hospital of Cologne pipeline card: 1 registered trials from official public datasets.Report a data error.